Check-Cap Ltd. is a clinical stage medical diagnostics company engaging in the development of ingestible imaging capsule system for colorectal cancer screening.
Net Income $-13,840,000, but an encouraging Quick Ratio of 3.69.
Looking at the volume, this asset can double its price is seconds.
on 5/28/2020 HC Wainwright Reiterated Chek Rating to Buy and the target...
12 months Consensus Price Target: $3
if you find my charts useful, please leave me "like" or "comment".
Please don't trade according to the ideas, rely on your own knowledge.
Looks like we are about to enter into range trading for some time, or small pull back to 2.5.
The idea here is that we are all waiting for some big announcement here.
This is LONG investment, but seeing a double bottom here is encouraging.
So it is just a matter of patience. Lots of patience.
Good luck everyone ;)
BLUE = Bear/Resistance